Dr Reddy’s Partners with GSK to Supply Emerging Markets

Dr Reddy’s Laboratories has announced a partnership with GlaxoSmithKline (GSK) to develop and market select products across emerging markets outside India.

Under the terms of the agreement, the latter will gain access to the former’s portfolio and future pipeline of more than 100 branded pharmaceuticals in therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management.

The products will be manufactured by the former and will be licensed and supplied to the latter in various emerging markets such as Africa, the Middle East, Latin America and Asia Pacific excluding India.

Revenues will be reported by GSK and be shared with Dr Reddy’s as per agreed terms. In certain markets, products will be co-marketed by both companies.